Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks

References

• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.306825
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5–115. doi:10.1093/eurjpc/zwab154
   PubMed Web of Science ®Google Scholar
• D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25Pt B):2935–2959. doi:10.1016/j.jacc.2013.11.005
   PubMed Web of Science ®Google Scholar
• Hageman S, Pennells L, Ojeda F; SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454. doi:10.1093/eurheartj/ehab309
   PubMed Web of Science ®Google Scholar
• de Vries TI, Cooney MT, Selmer RM; SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455–2467. doi:10.1093/eurheartj/ehab312
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. doi:10.1136/bmj.j2099
   PubMed Web of Science ®Google Scholar
• Marrugat J, D’Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634–638. doi:10.1136/jech.57.8.634
   PubMed Web of Science ®Google Scholar
• Marrugat J, Subirana I, Comín E, et al.; VERIFICA Investigators. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health. 2007;61(1):40–47. doi:10.1136/jech.2005.038505
   PubMed Web of Science ®Google Scholar
• Marrugat J, Vila J, Baena-Díez JM, et al. Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR. [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]. Rev Esp Cardiol. 2011;64(5):385–394. Spanish. doi:10.1016/j.recesp.2010.12.011
   PubMed Web of Science ®Google Scholar
• van Staa TP, Gulliford M, Ng ES, Goldacre B, Smeeth L. Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk? PLoS One. 2014;9(10):e106455. doi:10.1371/journal.pone.0106455
   PubMed Web of Science ®Google Scholar
• Veronesi G, Tunstall-Pedoe H, Ferrario MM, et al.; MORGAM Project. Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: implications for prevention. Eur J Prev Cardiol. 2017;24(4):437–445. doi:10.1177/2047487316679521
   Web of Science ®Google Scholar
• Karp I, Abrahamowicz M, Bartlett G, Pilote L. Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol. 2004;160(7):707–716. doi:10.1093/aje/kwh258
   Web of Science ®Google Scholar
• Livingstone S, Morales DR, Donnan PT, et al. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. 2021;2(6):e352–e361. doi:10.1016/S2666-7568(21)00088-X
   Google Scholar
• Cooper H, Wells S, Mehta S. Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged 65 years. Int J Epidemiol. 2022;51(2):604–614. doi:10.1093/ije/dyab116
   Web of Science ®Google Scholar
• Grau M, Subirana I, Elosua R, et al. Trends in cardiovascular risk factor prevalence (1995–2000–2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil. 2007;14(5):653–659. doi:10.1097/HJR.0b013e3281764429
   Google Scholar
• Redondo A, Benach J, Subirana I, et al. Trends in the prevalence, awareness, treatment, and control of cardiovascular risk factors across educational level in the 1995–2005 period. Ann Epidemiol. 2011;21(8):555–563. doi:10.1016/j.annepidem.2011.02.008
   Web of Science ®Google Scholar
• Marrugat J, Sala J, Manresa JM, et al.; REGICOR Investigators. Acute myocardial infarction population incidence and in-hospital management factors associated to 28-day case-fatality in the 65 year and older. Eur J Epidemiol. 2004;19(3):231–237. doi:10.1023/B:EJEP.0000020446.57845.b0
   Web of Science ®Google Scholar
• Dégano IR, Marrugat J, Grau M, et al. The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass index. Sci Rep. 2017;7(1):12370. doi:10.1038/s41598-017-10775-3
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Byung-Ho N. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handb Stat. 2004;23:1–25.
   Google Scholar
• Pencina MJ, D’Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21. doi:10.1002/sim.4085
   PubMed Web of Science ®Google Scholar
• Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32(14):2430–2442. doi:10.1002/sim.5647
   PubMed Web of Science ®Google Scholar
• Paige E, Barrett J, Pennells L, et al. Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: an individual-participant-data meta-analysis. Am J Epidemiol. 2017;186(8):899–907. doi:10.1093/aje/kwx149
   Web of Science ®Google Scholar
• Bell K, Hayen A, McGeechan K, Neal B, Irwig L. Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk. Eur J Prev Cardiol. 2012;19(6):1474–1485. doi:10.1177/1741826711424494
   Web of Science ®Google Scholar
• Pool LR, Ning H, Wilkins J, Lloyd-Jones DM, Allen NB. Use of long-term cumulative blood pressure in cardiovascular risk prediction models. JAMA Cardiol. 2018;3(11):1096–1100. doi:10.1001/jamacardio.2018.2763
   PubMed Web of Science ®Google Scholar
• Cho IJ, Sung JM, Chang HJ, Chung N, Kim HC. Incremental value of repeated risk factor measurements for cardiovascular disease prediction in middle-aged Korean adults: results from the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort). Circ Cardiovasc Qual Outcomes. 2017;10(11):e004197. doi:10.1161/CIRCOUTCOMES.117.004197
   Web of Science ®Google Scholar
• 2018 prevention guidelines tool risk calculator [homepage on the internet]. American Heart Association. Available from: http://static.heart.org/riskcalc/app/index.html#!/baseline-risk. Accessed September 19, 2022. Accessed May 12, 2022.
   Google Scholar
• Marrugat J, Subirana I, Ramos R, et al.; FRESCO Investigators. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: the FRESCO Study. Prev Med. 2014;61:66–74. doi:10.1016/j.ypmed.2013.12.031
   Web of Science ®Google Scholar
• Conroy RM, Pyörälä K, Fitzgerald AP, et al.; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi:10.1016/S0195-668X(03)00114-3
   PubMed Web of Science ®Google Scholar
• Dégano IR, Salomaa V, Veronesi G, et al.; Acute Myocardial Infarction Trends in Europe (AMITIE) Study Investigators. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 2015;101(17):1413–1421. doi:10.1136/heartjnl-2014-307310
   PubMed Web of Science ®Google Scholar